HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dimas Echeverria Selected Research

RNAi Therapeutics

1/2022An RNAi therapeutic targeting hepatic DGAT2 in a genetically obese mouse model of nonalcoholic steatohepatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dimas Echeverria Research Topics

Disease

6Huntington Disease (Huntington's Disease)
05/2024 - 10/2016
5Neurodegenerative Diseases (Neurodegenerative Disease)
05/2024 - 08/2016
4Non-alcoholic Fatty Liver Disease
04/2024 - 01/2022
4Inflammation (Inflammations)
04/2024 - 01/2022
4Fibrosis (Cirrhosis)
04/2024 - 01/2022
4Nervous System Diseases (Neurological Disorders)
01/2022 - 10/2016
3Alzheimer Disease (Alzheimer's Disease)
05/2024 - 12/2023
3Neoplasms (Cancer)
04/2024 - 06/2015
2Brain Neoplasms (Brain Tumor)
04/2024 - 01/2018
2Liver Cirrhosis (Hepatic Cirrhosis)
04/2024 - 10/2023
2Metabolic Diseases (Metabolic Disease)
04/2024 - 10/2023
2Retinal Diseases
03/2024 - 09/2023
2Vitiligo
11/2023 - 01/2022
2Skin Diseases (Skin Disease)
11/2023 - 01/2022
2Obesity
01/2022 - 01/2018
1Glioblastoma (Glioblastoma Multiforme)
04/2024
1Disease Progression
02/2024
1COVID-19
01/2023
1Alopecia Areata
01/2022
1Liver Diseases (Liver Disease)
01/2022
1Lichen Planus (Lichen Ruber Planus)
01/2022
1Fatty Liver
01/2022
1Pre-Eclampsia (Preeclampsia)
11/2018
1Glioma (Gliomas)
01/2018
1Type 2 Diabetes Mellitus (MODY)
01/2018
1Chronic Disease (Chronic Diseases)
01/2018
1Carcinogenesis
06/2015
1Carcinoma (Carcinomatosis)
06/2015
1Body Weight (Weight, Body)
06/2015

Drug/Important Bio-Agent (IBA)

9Small Interfering RNA (siRNA)IBA
05/2024 - 08/2016
5Proteins (Proteins, Gene)FDA Link
04/2024 - 01/2018
4OligonucleotidesIBA
04/2024 - 10/2016
4Triglycerides (Triacylglycerol)IBA
04/2024 - 01/2022
3Apolipoproteins E (ApoE)IBA
05/2024 - 12/2023
3CollagenIBA
04/2024 - 07/2023
3Messenger RNA (mRNA)IBA
01/2022 - 01/2018
2Monocarboxylic Acid TransportersIBA
04/2024 - 10/2023
2Lactic Acid (Lactate)FDA LinkGeneric
04/2024 - 10/2023
1CholesterolIBA
02/2024
1Apolipoprotein E4IBA
02/2024
1Amyloid (Amyloid Fibrils)IBA
02/2024
1EnzymesIBA
11/2023
1Janus KinasesIBA
11/2023
1Antiviral Agents (Antivirals)IBA
01/2023
1Nuclear RNAIBA
01/2022
1DiglyceridesIBA
01/2022
1ChemokinesIBA
01/2022
1InterferonsIBA
01/2022
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2018
1Antisense OligonucleotidesIBA
01/2018
1Dietary FiberFDA Link
01/2018
1N 30IBA
06/2015
1BiguanidesIBA
06/2015
1Phenformin (Fenformin)IBA
06/2015
1Metformin (Glucophage)FDA LinkGeneric
06/2015
1BuforminIBA
06/2015

Therapy/Procedure

5Therapeutics
04/2024 - 08/2016
2Intravitreal Injections
03/2024 - 09/2023
1RNAi Therapeutics
01/2022
1Transplantation
01/2018